Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective
Aim: The cost–effectiveness of treatment options (anticholinergics, β3-adrenoceptor agonists, onabotulinumtoxinA, sacral nerve stimulation and percutaneous tibial stimulation [the latter two including new rechargeable neurostimulators]) for the management of overactive bladder (OAB) were compared...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2023-01-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |